Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Fraser

Showing results (551-560 of 610) with videos related to

Pageof 61
Sort By:
Journal of Medicinal Chemistry|November 28, 2006
Discovery of a new class of macrocyclic antagonists to the human motilin receptorEric Marsault, Hamid R Hoveyda, Mark L Peterson, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridinesGeorge M Buckley, Richard Fosbeary, Joanne L Fraser, et al.
Angewandte Chemie (International Ed. in English)|September 20, 2019
An [Fe<sup>III</sup> <sub>34</sub> ] Molecular Metal OxideAlice E Dearle, Daniel J Cutler, Hector W L Fraser, et al.
Contemporary Clinical Trials Communications|July 21, 2025
Tackling burnout in Australian doctors by blending a web-based cognitive-behavioural therapy program with telehealth psychological support - protocol for a three-arm randomised-controlled trialM J Coleshill, M J Black, K Luck, et al.
Gastroenterology|January 10, 2020
Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in MiceSydney Lavoie, Eunyoung Chun, Sena Bae, et al.
Journal of Medicinal Chemistry|January 30, 2025
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor ModelsGuillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2008
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine bindingGeorge M Buckley, Thomas A Ceska, Joanne L Fraser, et al.
American Journal of Human Genetics|October 20, 2021
Establishing risk of vision loss in Leber hereditary optic neuropathyM Isabel G Lopez Sanchez, Lisa S Kearns, Sandra E Staffieri, et al.
Nature Medicine|January 8, 2025
Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trialEmilie Combet, Laura Haag, Janice Richardson, et al.
Emergency Medicine Australasia : EMA|September 18, 2020
Using non-mydriatic fundus photography to detect fundus pathology in Australian metropolitan emergency departments: A prospective prevalence and diagnostic accuracy studyHamish P Dunn, Kai Zong Teo, James Wp Smyth, et al.
Pageof 61

Showing results (551-560 of 610) with videos related to

Sort By:
Pageof 61
Journal of Medicinal Chemistry|November 28, 2006
Discovery of a new class of macrocyclic antagonists to the human motilin receptorEric Marsault, Hamid R Hoveyda, Mark L Peterson, et al.
Bioorganic & Medicinal Chemistry Letters|May 27, 2008
IRAK-4 inhibitors. Part III: a series of imidazo[1,2-a]pyridinesGeorge M Buckley, Richard Fosbeary, Joanne L Fraser, et al.
Angewandte Chemie (International Ed. in English)|September 20, 2019
An [Fe<sup>III</sup> <sub>34</sub> ] Molecular Metal OxideAlice E Dearle, Daniel J Cutler, Hector W L Fraser, et al.
Contemporary Clinical Trials Communications|July 21, 2025
Tackling burnout in Australian doctors by blending a web-based cognitive-behavioural therapy program with telehealth psychological support - protocol for a three-arm randomised-controlled trialM J Coleshill, M J Black, K Luck, et al.
Gastroenterology|January 10, 2020
Expression of Free Fatty Acid Receptor 2 by Dendritic Cells Prevents Their Expression of Interleukin 27 and Is Required for Maintenance of Mucosal Barrier and Immune Response Against Colorectal Tumors in MiceSydney Lavoie, Eunyoung Chun, Sena Bae, et al.
Journal of Medicinal Chemistry|January 30, 2025
Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor ModelsGuillaume Dutheuil, Killian Oukoloff, Julien Korac, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2008
IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine bindingGeorge M Buckley, Thomas A Ceska, Joanne L Fraser, et al.
American Journal of Human Genetics|October 20, 2021
Establishing risk of vision loss in Leber hereditary optic neuropathyM Isabel G Lopez Sanchez, Lisa S Kearns, Sandra E Staffieri, et al.
Nature Medicine|January 8, 2025
Remotely delivered weight management for people with long COVID and overweight: the randomized wait-list-controlled ReDIRECT trialEmilie Combet, Laura Haag, Janice Richardson, et al.
Emergency Medicine Australasia : EMA|September 18, 2020
Using non-mydriatic fundus photography to detect fundus pathology in Australian metropolitan emergency departments: A prospective prevalence and diagnostic accuracy studyHamish P Dunn, Kai Zong Teo, James Wp Smyth, et al.
Pageof 61